Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy With Partial-onset Seizures”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Large-scale testing (Phase 3)Study completedNCT02477839
What this trial is testing

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures

Who this might be right for
Epilepsy With Partial-onset Seizures
UCB BIOSCIENCES, Inc. 255
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Testing effectiveness (Phase 2)Study completedNCT00175825
What this trial is testing

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Who this might be right for
Epilepsy
UCB Pharma 210
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Testing effectiveness (Phase 2)Study completedNCT01866111
What this trial is testing

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 437
Post-approval studies (Phase 4)Not Yet RecruitingNCT06534502
What this trial is testing

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

Who this might be right for
SeizuresSeizures, FocalSeizure, Partial Onset+4 more
Azurity Pharmaceuticals 40
Post-approval studies (Phase 4)Study completedNCT01229735
What this trial is testing

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Korea Co., Ltd. 343
Post-approval studies (Phase 4)Study completedNCT00659958
What this trial is testing

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

Who this might be right for
Epilepsy
Eisai Inc. 32
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06443463
What this trial is testing

Long-term Safety and Tolerability of BHV-7000

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 660
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Large-scale testing (Phase 3)Study completedNCT01964560
What this trial is testing

A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 540
Large-scale testing (Phase 3)Study completedNCT01243177
What this trial is testing

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Who this might be right for
EpilepsyMonotherapy
UCB BIOSCIENCES GmbH 888
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Testing effectiveness (Phase 2)Study completedNCT00437281
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 65
Testing effectiveness (Phase 2)Study completedNCT01161524
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Who this might be right for
Epilepsy
Eisai Inc. 133
Post-approval studies (Phase 4)Study completedNCT02726074
What this trial is testing

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
Eisai Korea Inc. 106
Large-scale testing (Phase 3)Study completedNCT01832038
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Pharma SA 473
Large-scale testing (Phase 3)Study completedNCT00160615
What this trial is testing

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

Who this might be right for
Epilepsy, Partial
UCB Japan Co. Ltd. 154
Testing effectiveness (Phase 2)Study completedNCT00465517
What this trial is testing

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Who this might be right for
Partial EpilepsyCatamenial Epilepsy
Marinus Pharmaceuticals 147
Early research (Phase 1)Study completedNCT04903314
What this trial is testing

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 26
Load More Results